Loading company…
Varinos develops genomic tests for reproductive health, infertility and microbiome analysis.
Founded in 2017, Varinos develops clinical tests using genomic technology, with a focus on infertility, reproductive health and microbiome analysis. Based in Tokyo, Japan, it raised an undisclosed amount in Series D funding in March 2026, as part of a larger JPY 1.25 billion Series D and debt funding round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in